Back to top
more

Anthem, Inc. (ANTM)

(Delayed Data from NYSE)

$261.70 USD

261.70
1,184,666

+0.11 (0.04%)

Updated May 3, 2019 04:00 PM ET

After-Market: $261.69 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Centene (CNC) Announces Solid Financial Guidance for 2021

by Zacks Equity Research

Centene (CNC) provides an impressive 2021 guidance for key metrics owing to its strong inorganic growth story and a healthy revenue stream.

Anthem (ANTM) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

Anthem (ANTM) closed at $308.64 in the latest trading session, marking a -1.73% move from the prior day.

Anthem (ANTM) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

In the latest trading session, Anthem (ANTM) closed at $313.75, marking a -1.47% move from the previous day.

Humana (HUM) to Buy Remaining iCare Shares to Expand Medicare

by Zacks Equity Research

Humana (HUM) to acquire rest of iCare's shares from CFI to extend its Medicare business in Wisconsin.

UnitedHealth's (UNH) Solid Earnings View Buoys Investor Hopes

by Zacks Equity Research

UnitedHealth (UNH) provides an upbeat earnings guidance for 2020 and 2021, prompted by strong growth in its UnitedHealthcare and Optum segments.

Is Anthem (ANTM) a Potential Stock for Value Investors?

by Zacks Equity Research

Is Anthem (ANTM) a great pick from the value investor's perspective right now? Read on to know more.

Cigna (CI) Expands Presence on Exchanges in North Carolina (Revised)

by Zacks Equity Research

Cigna (CI) expands ACA offering in additional counties across North Carolina with enhanced benefits.

Srijita Guha headshot

3 Healthcare Stocks to Keep Gaining From Telehealth Services

by Srijita Guha

Amid the coronavirus pandemic, we pick three healthcare stocks that are poised to grow on the back of virtual care facilities.

Magellan Health's (MGLN) Arm Enhances Mental Health Solutions

by Zacks Equity Research

Magellan Health's (MGLN) behavioral and specialty health subsidiary introduces programs to help people deal with mental health illnesses amid festivities.

Humana (HUM) Enhances Its Services in Washington Counties

by Zacks Equity Research

Humana (HUM) recently adds to its services in Washington. Eligible members in Benton, Walla Walla and Franklin counties will now get more healthcare options.

Why You Should Add Molina Healthcare (MOH) to Your Portfolio

by Zacks Equity Research

Banking on strategic measures and growing revenues, Molina Healthcare (MOH) holds enough potential to reap benefits for investors.

Humana (HUM) Joins Envision for Better Healthcare in Florida

by Zacks Equity Research

Humana (HUM) expands partnership with Envision Healthcare to provide in-network medical care to its commercial, Medicare and Medicaid members in Florida.

Humana (HUM) to Offer MA Plans in Massachusetts for First Time

by Zacks Equity Research

Humana's (HUM) Medicare Advantage plans to make a debut in Massachusetts for fortifying the company's foothold in the state.

Humana (HUM) Inks Deal to Better Serve Members in Kansas Area

by Zacks Equity Research

Humana (HUM) partners Prime Healthcare to mete out better healthcare facilities to members residing in the Kansas region.

Humana (HUM), Northwell Tie Up for Better Health Outcome

by Zacks Equity Research

Humana (HUM) partners with Northwell to provide improved healthcare services in the New York metropolitan region.

Cigna (CI) Q3 Earnings & Revenues Beat Estimates, Grow Y/Y

by Zacks Equity Research

Cigna's (CI) Q3 results reflect a strong fundamental performance across its businesses besides the return of medical utilization to more typical levels and COVID-19-related adversities.

Magellan's (MGLN) Q3 Earnings Top Estimates, Decline Y/Y

by Zacks Equity Research

Magellan Health's (MGLN) third-quarter results benefit from strong specialty pharmacy operations, partly offset by escalating expenses.

Anthem (ANTM) Q3 Earnings Surpass Estimates, Decline Y/Y

by Zacks Equity Research

Anthem's (ANTM) Q3 earnings benefit from strong Medicaid and Medicare businesses as well as solid contributions from its Commercial & Specialty Business and Government Business.

Should Value Investors Buy Anthem (ANTM) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Anthem (ANTM) Beats Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Anthem (ANTM) delivered earnings and revenue surprises of 3.96% and 2.82%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Anthem (ANTM) to Report Q3 Earnings: What's in the Cards?

by Zacks Equity Research

Anthem's (ANTM) third-quarter earnings results are likely to reflect elevated costs and a softness in Commercial business line.

Earnings Preview: Anthem (ANTM) Q3 Earnings Expected to Decline

by Zacks Equity Research

Anthem (ANTM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Humana (HUM) Expands in Tennessee to Boost Medicare Business

by Zacks Equity Research

Humana (HUM) expands Medicare Advantage in 31 rural counties of the Knoxville, Memphis, Nashville regions as well as drives benefits for veterans.

Humana Adds Retail Pharmacies to Medicare Part D Network

by Zacks Equity Research

Humana (HUM) adds Kroger Health and its chain of pharmacies to its preferred stand-alone Medicare Part D pharmacy network, to be effective 2021.

The Zacks Analyst Blog Highlights: Mastercard, JPMorgan, Eli Lilly, Caterpillar and Anthem

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Mastercard, JPMorgan, Eli Lilly, Caterpillar and Anthem